Alkem Share Price (ALKEM)
Check the latest share price of Alkem, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 11:32AM, 08 Jul 2025
NSE
Alkem Stock Performance
Get live Alkem share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹4,790.6Day's Price Range₹4,885.552 Week's Low
52 Week's High
₹4,491.6552-Week Price Range₹6,439.9
| Returns % | |
| 1 Month Return | + 0.08 % |
| 3 Month Return | + 0.83 % |
| 1 Year Return | -6.6 % |
| 3 Year Return | + 56.08 % |
| 5 Year Return | + 100.9 % |
| Market Stats | |
| Previous Close | ₹4,877.30 |
| Open | ₹4,793.30 |
| Volume | 30.14K |
| Upper Circuit | ₹5,365.00 |
| Lower Circuit | ₹4,389.60 |
Alkem Fundamentals & Key Indicators
Check Alkem market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹58,315.44 Cr
Return on Equity (ROE)
17.56
PE Ratio (TTM)
26.93
Return on capital employed (ROCE)
17.28
Industry PE ratio
54.71
Beta (LTM)
0.6
P/B Ratio
5.6
Dividend Yield
0.81
PEG Ratio
0.87
Quarterly Earnings Growth YOY
6.09
EPS (TTM)
151.52
Sector
Pharmaceuticals
Book Value
862.57
Technical Analysis
Bearish
View Technical Analysis
How to invest in Alkem?
Investing in Alkem is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Alkem or ALKEM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Alkem or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Alkem with just a few clicks!
Alkem Stock's Interest Amongst Investors
Alkem Valuation
Track how Alkem P/E has moved over time to understand its valuation trends.
Alkem in the last 5 years
Lowest (20.07x)
March 24, 2021
Today (26.93x)
July 7, 2025
Industry (54.71x)
July 7, 2025
Highest (44.21x)
August 9, 2023
Today’s Price to Earnings Ratio: 26.93x
Alkem Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Alkem.
based on 21 analysts
42.86%
Buy
19.05%
Hold
38.10%
Sell
42.86% of analysts recommend a 'HOLD' rating for Alkem. Average target price of ₹5187.81
Source: S&P Global Market Intelligence
Alkem Share Price Target
Get share price movements and forecasts by analysts on Alkem.
Alkem price forecast by 21 analysts
Upside of6.37%
High
₹6835
Target
₹5187.81
Low
₹4030
Alkem target price ₹5187.81, a slight upside of 6.37% compared to current price of ₹4792.4. According to 21 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Alkem revenue growth forecast
Expected growth rate Q1, FY2027:22.59%
Forecast
Actual
Including amortisation and stock based compensations
Alkem EPS growth forecast
EPS estimate Q1, FY2027:28.11%
Forecast
Actual
Source: S&P Global Market Intelligence
Alkem Financial Results
Get the annual and quarterly financial summary of Alkem, including revenue, profit, loss and more.
Indices Featuring Alkem Stock
Check stock indices that include Alkem.
Alkem Earnings and Dividends
View detailed summary of the earnings and dividend history of Alkem.
Alkem Laboratories Ltd Earnings Results
Alkem Laboratories Ltd’s net profit jumped 4.19% since last year same period to ₹305.86Cr in the Q4 2024-2025. On a quarterly growth basis, Alkem Laboratories Ltd has generated -51.13% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlkem Laboratories Ltd Dividends February,2025
In the quarter ending December 2024, Alkem Laboratories Ltd has declared dividend of ₹37 - translating a dividend yield of 1.58%.
Read More about Dividends
Alkem Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Alkem.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.13% | 0.00 | |
| Foreign Institutions | 9.41% | 0.00 | |
| Mutual Funds | 14.97% | 0.00 | |
| Retail Investors | 16.05% | 0.00 | |
| Others | 4.45% | 0.00 |
Alkem vs Peers
Compare market cap, revenue, PE, and other key metrics of Alkem with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 58,315.44 | 20.18% | 0.56 | 1,811 | 12,667 | |
| HOLD | 23,915.39 | 12.41% | 0.53 | 492 | 2,461 | |
| HOLD | 41,859.47 | 119.98% | 0.69 | 354 | 5,553 | |
| BUY | 10,371.91 | 12.58% | 0.64 | 119 | 547 | |
| BUY | 5,681.53 | 20.94% | 0.54 | 69 | 571 |
Alkem News & Key Events
Latest news and events in one place to help you make informed investing decisions in Alkem.
Alkem Laboratories Declares 400% Final Dividend - 14 Jun, 2025
Alkem Laboratories Ltd announced a 400% final dividend of Rs 8 per share for FY25, with a record date set for August 8, 2025. The company reported a 6% increase in net profit to Rs 322 crore for Q4 FY25, driven by strong domestic growth. Revenue for FY25 rose to Rs 12,964 crore from Rs 12,667 crore in FY24.Alkem Labs Files Trademark Infringement Suit - 13 Jun, 2025
Alkem Laboratories has filed a lawsuit against an IPO-bound company for trademark infringement regarding the name 'Allchem.' The company seeks a permanent injunction and damages of ₹2 crore.Alkem Laboratories Reports Decline in Financial Performance - 12 Jun, 2025
Alkem Laboratories reported a 13.55% decline in net sales to Rs 2,044.94 crore for March 2025, with net profit down 14.78% to Rs 276.94 crore. EBITDA also fell by 16.88%. The stock has seen negative returns of -11.01% over the last six months.Alkem Laboratories Sees Third Straight Session Gain - 10 Jun, 2025
Alkem Laboratories Ltd is up 2.08% today, marking its third consecutive session of gains. However, the stock is down 1.81% over the past year, underperforming both the NIFTY and Nifty Pharma index. The stock's PE ratio stands at 27.89 based on TTM earnings.Stake Sale and Ratings Update for Alkem Laboratories - 04 Jun, 2025
Alkem Laboratories faced notable events, including a stake sale by Jayanti Sinha, a large block deal, and an updated target price from I-Sec.Alkem Promoter to Offload Stake via Block Deal - 03 Jun, 2025
Jayanti Sinha, a promoter of Alkem Laboratories, plans to sell a 1.42% stake through a block deal worth ₹825 crore at a floor price of ₹4,850 per share, reflecting a 3% discount. Alkem's recent financial results showed a year-on-year profit rise but fell short of estimates, impacting stock performance.Alkem Reports Mixed Q4 Results Amid Analyst Downgrades - 30 May, 2025
Alkem Laboratories reported a 6% rise in Q4 net profit to Rs 322 crore, but Jefferies downgraded the stock due to margin concerns. Nomura maintained a Buy rating, anticipating growth from the upcoming Semaglutide launch despite mixed guidance for FY26.Alkem Laboratories Reports Q4 Results, Misses Estimates - 29 May, 2025
Alkem Laboratories announced a 4% increase in Q4 net profit to ₹306 crore, falling short of market expectations. Revenue and EBITDA also missed estimates, despite growth in the India business and non-US markets. The company declared an ₹8 dividend.
Insights on Alkem Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, ALKEM stock has moved up by 0.6%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 14.01% to 14.97% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 54.3% return, outperforming this stock by 60.9%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.6% return, outperforming this stock by 72.5%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 16.18% to 16.05% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 10.15% to 9.41% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 55.66% to 55.13% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 688.64 Cr → 305.86 Cr (in ₹), with an average decrease of 30.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 3.54K Cr → 3.28K Cr (in ₹), with an average decrease of 3.7% per quarter
About Alkem
With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.
Revenue: ₹3,143.75Cr as on March 2025 (Q4 FY25)
Net Profit: ₹323.01Cr as on March 2025 (Q4 FY25)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
| Organisation | Alkem Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Basudeo N Singh |
| E-voting on shares | Click here to vote |
Mutual Funds that own Alkem
Check out the Mutual Funds with significant holdings in Alkem.
FAQs
What is Alkem share price today?
Alkem share price today stands at ₹4792.4, Open: ₹4793.3, Previous Close: ₹4877.3, High: ₹4885.5, Low: ₹4790.6, 52 Week High: ₹6439.9, 52 Week Low: ₹4491.65.
What is today's traded volume of Alkem?
Today's traded volume of Alkem is 30.14K. Which means that 30.14K shares of Alkem were bought and sold on the stock market during today's trading session.
What is Alkem's market cap today?
Today's market capitalisation of Alkem is ₹58,315.44 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Alkem?
Alkem’s 52 week high is ₹6439.9 and 52 week low is ₹4491.65. The current share price of Alkem is ₹4792.4, which is -25.58% down from its 52 week high and 6.70% up from its 52 week low.